← Leaderboards
Louis Michael Messina
University Of California San Francisco
$5,766,947
Attributed
$5,766,947
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $507.8K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,766,947 · 3
By mechanism
R01$5,306,322 · 2
R21$460,625 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Chandan K Sen$19,652,718
- Mandana Khalili$12,345,266
- Darren B Schneider$608,850
- Ian D Meng$15,848,132
- Holly A. Ingraham$28,179,658
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseArteriesHypercholesterolemiaOxidant StressBlood VesselsLimb StructureInflammatoryDiabetes MellitusImpairmentEpidemicIn VivoWild Type MouseStem CellsTetrahydrobiopterinFunctional DisorderPeripheral Arterial DiseaseCell PhysiologyNeovascularizationResponseTransplantationIschemiaAffectDisability
Grant awards (15)
Combined effects of aging and type 2 diabetes on wound healing in a humanized mouse model$209,375
R21 · FY2021 · AG · contact PI
Combined effects of aging and type 2 diabetes on wound healing in a humanized mouse model$251,250
R21 · FY2020 · AG · contact PI
Hypercholesterolemia Impairs Stem Cell-Mediated Post-Ischemic Neovascularization$418,750
R01 · FY2017 · HL · contact PI
Hypercholesterolemia Impairs Stem Cell-Mediated Post-Ischemic Neovascularization$418,750
R01 · FY2016 · HL · contact PI
Hypercholesterolemia Impairs Stem Cell-Mediated Post-Ischemic Neovascularization$412,468
R01 · FY2015 · HL · contact PI
Hypercholesterolemia Impairs Stem Cell-Mediated Post-Ischemic Neovascularization$418,750
R01 · FY2014 · HL · contact PI
Mesenchymal stem cells in the treatment of hindlimb ischemia in diabetic mice$387,595
R01 · FY2013 · HL · contact PI
Mesenchymal stem cells in the treatment of hindlimb ischemia in diabetic mice$407,138
R01 · FY2012 · HL · contact PI
Mesenchymal stem cells in the treatment of hindlimb ischemia in diabetic mice$411,250
R01 · FY2011 · HL · contact PI
Mesenchymal stem cells in the treatment of hindlimb ischemia in diabetic mice$411,250
R01 · FY2010 · HL · contact PI
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA$507,824
R01 · FY2008 · HL · contact PI
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA$385,198
R01 · FY2007 · HL · contact PI
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA$369,849
R01 · FY2006 · HL · contact PI
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA$378,750
R01 · FY2005 · HL
OVEREXPRESSION OF ENOS IN CRITICAL LIMB ISCHEMIA$378,750
R01 · FY2004 · HL